| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥467.1B | ¥466.2B | +0.2% |
| Operating Income | ¥26.1B | ¥26.1B | +0.1% |
| Ordinary Income | ¥35.1B | ¥30.8B | +13.9% |
| Net Income | ¥17.3B | ¥19.8B | -12.6% |
| ROE | 2.5% | 2.9% | - |
FY2026 Q3 cumulative results show revenue of 467.1B yen (YoY +0.2%), operating income of 26.1B yen (+0.1%), ordinary income of 35.1B yen (+13.9%), and net income of 17.3B yen (-12.6%). Revenue and operating income remained essentially flat, while ordinary income expanded significantly driven by 9.9B yen in foreign exchange gains and 3.5B yen in dividend income. Net income declined despite higher ordinary income due to extraordinary losses of 11.6B yen, including 10.4B yen in disaster losses, and an effective tax rate of 35.4%. The company maintains flat operational performance with profitability improvement masked by non-operating factors, while earnings quality is impacted by substantial extraordinary items.
Revenue of 467.1B yen increased 0.2% YoY, essentially flat with prior year. The Fine Chemicals Division generated 372.9B yen (79.8% of total revenue) with segment profit of 21.2B yen at a 5.7% margin, serving as the primary revenue driver. The Facilities Division contributed 33.7B yen with 2.5B yen profit at 7.5% margin, while the Fundamental Chemicals Division posted 57.6B yen revenue but only 1.8B yen profit at a 3.1% margin. The Ferro Chemicals Division recorded 13.9B yen revenue with 2.0B yen profit at 14.1% margin, the highest margin across all segments. The Trading Division generated 14.7B yen with 0.9B yen profit at 5.9% margin.
Gross profit of 101.4B yen yielded a 21.7% margin, consistent with the prior period structure. SG&A expenses totaled 75.3B yen (16.1% of revenue), resulting in operating income of 26.1B yen and an operating margin of 5.6%. Operating income growth of 0.1% reflects stable but stagnant core business profitability.
Ordinary income of 35.1B yen increased 13.9% YoY, driven by 15.5B yen in non-operating income. Foreign exchange gains of 9.9B yen represented the largest non-operating item, contributing 37.8% of operating income equivalent. Dividend income of 3.5B yen and interest income of 0.7B yen also supported ordinary income. Non-operating expenses of 6.5B yen included 3.5B yen in interest expense, resulting in net non-operating income of 9.0B yen.
Net income of 17.3B yen declined 12.6% YoY despite higher ordinary income. Extraordinary income of 3.3B yen from securities sales was offset by extraordinary losses of 11.6B yen, including disaster losses of 10.4B yen and asset disposal losses of 1.1B yen. Profit before tax of 26.8B yen was reduced by income tax expense of 9.5B yen (35.4% effective rate), yielding net income attributable to owners of the parent. The substantial gap between ordinary income growth (+13.9%) and net income decline (-12.6%) reflects the impact of non-recurring extraordinary losses.
This represents a revenue flat/profit mixed pattern, with operating profit essentially unchanged, ordinary profit improved by non-operating gains, and net profit declined due to extraordinary losses.
The Fine Chemicals Division is the core business, generating 372.9B yen in revenue (79.8% share) and 21.2B yen in operating income with a 5.7% margin. This segment increased revenue by 0.6% YoY (from 370.5B yen) and operating profit by negative 15.3% (from 25.1B yen), indicating margin compression within the largest division.
The Ferro Chemicals Division posted 13.9B yen revenue and 2.0B yen operating income at a 14.1% margin, the highest across all segments. Revenue declined 20.4% YoY (from 17.5B yen) while profit decreased 29.2% (from 2.8B yen), suggesting volume contraction in a higher-margin specialty business.
The Facilities Division contributed 33.7B yen in revenue with 2.5B yen operating income at a 7.5% margin. This segment grew revenue by 27.1% YoY and operating profit by 2.0%, demonstrating expansion in engineering and construction services.
The Fundamental Chemicals Division generated 57.6B yen revenue with only 1.8B yen operating income, yielding a 3.1% margin. This segment decreased revenue by 3.9% YoY but recovered from a prior year loss of negative 5.2B yen to positive profit, indicating operational turnaround but persistent margin pressure.
The Trading Division recorded 14.7B yen revenue and 0.9B yen operating income at 5.9% margin. Revenue increased 16.8% YoY while profit declined 5.4%, reflecting volume growth with margin dilution.
Segment adjustments totaled negative 2.3B yen (prior year negative 0.1B yen), primarily due to intersegment transaction eliminations, reducing consolidated operating income from 28.4B yen segment total to 26.1B yen reported.
[Profitability] Operating margin of 5.6% remained flat YoY at 5.6%, while net profit margin of 3.7% compressed from prior levels due to extraordinary losses. ROE of 2.5% represents significantly weak capital efficiency, substantially below historical performance and indicating underutilization of equity capital. EBIT margin of 5.6% aligns with operating margin, confirming limited operational leverage. Gross margin of 21.7% demonstrates stable product pricing and cost structure at the production level, but SG&A ratio of 16.1% leaves limited operational profit margin. [Financial Health] Equity ratio of 54.4% (697.2B yen equity against 1,282.8B yen total assets) reflects a conservative capital structure with majority equity financing. Current ratio of 234.2% (613.7B yen current assets / 262.0B yen current liabilities) indicates strong short-term liquidity coverage. Debt-to-equity ratio of 0.84x (585.5B yen total liabilities / 697.2B yen equity) demonstrates moderate financial leverage. Financial leverage of 1.84x (total assets / equity) supports ROE calculation but remains below aggressive levels. Interest coverage of 7.37x (operating income / interest expense) provides adequate debt service capacity. [Cash Quality] Cash and deposits of 182.6B yen increased from prior period, representing 14.2% of total assets and providing 6.68x coverage of short-term borrowings (27.4B yen). Investment securities of 109.8B yen increased 34.2% YoY, indicating active portfolio expansion with associated market risk. Retained earnings of 552.2B yen form the core of equity capital, demonstrating accumulated profitability over time. [Investment Efficiency] Asset turnover of 0.364x indicates low asset utilization, contributing to depressed ROE through DuPont analysis. Inventory of 68.7B yen in finished goods plus 65.9B yen raw materials and 68.6B yen work-in-process total 203.2B yen, representing 43.5% of revenue and suggesting inventory turnover of 203 days. Trade receivables of 169.0B yen represent 36.2% of revenue, implying 132-day collection period. Working capital efficiency measured by cash conversion cycle of 276 days indicates substantial capital tied up in operations.
Cash and deposits increased to 182.6B yen, representing strong liquidity positioning and 6.68x coverage of short-term borrowings. Operating profit of 26.1B yen combined with ordinary income contributions from foreign exchange gains of 9.9B yen and dividend income of 3.5B yen supported cash accumulation, though actual operating cash flow data is not disclosed for the quarterly period. Trade receivables of 169.0B yen with a 132-day collection cycle and inventory of 203.2B yen with 203-day turnover indicate working capital consumes substantial operational cash, with a cash conversion cycle of 276 days limiting free cash generation. Investment securities increased 27.9B yen (+34.2%) to 109.8B yen, suggesting significant investing outflows for portfolio expansion, partially offset by 3.3B yen in securities sale proceeds recorded as extraordinary income. Long-term borrowings of 300.2B yen and current portion of long-term debt of 90.8B yen indicate ongoing debt financing, while retained earnings growth of 17.3B yen less dividends funded equity expansion. The combination of adequate cash coverage for short-term obligations and moderate leverage provides financial flexibility, though working capital management remains an area requiring improvement to enhance cash generation efficiency.
Ordinary income of 35.1B yen versus operating income of 26.1B yen shows non-operating net contribution of 9.0B yen, representing 34.5% of ordinary income. Non-operating income of 15.5B yen comprises foreign exchange gains of 9.9B yen (63.9% of non-operating income), dividend income of 3.5B yen (22.6%), interest income of 0.7B yen, and other income of 1.4B yen. The 9.9B yen foreign exchange gain represents 37.8% of operating income, indicating significant dependency on currency movements for profitability enhancement. This level of FX contribution introduces volatility and raises sustainability concerns as exchange rates fluctuate. Non-operating expenses of 6.5B yen included interest expense of 3.5B yen and other expenses of 0.3B yen, resulting in interest coverage of 7.37x. Extraordinary items show 3.3B yen gain from securities sales offset by 11.6B yen in losses, including 10.4B yen disaster loss and 1.1B yen asset disposal loss, totaling net extraordinary loss of 8.3B yen. These non-recurring items significantly impacted net income, reducing it from ordinary income of 35.1B yen to net income of 17.3B yen after taxes. Comprehensive income totaled 32.5B yen, including 20.1B yen in unrealized gains on securities valuation, negative 3.7B yen foreign exchange translation adjustments, and negative 1.2B yen pension remeasurements, demonstrating substantial mark-to-market effects beyond reported net income. The quality of earnings is constrained by high non-operating income dependency, significant extraordinary losses, and working capital inefficiency evidenced by 203-day inventory turnover and 132-day receivables collection, suggesting profit recognition outpaces cash generation.
Full-year guidance shows revenue of 665.0B yen (YoY +6.7%), operating income of 45.0B yen (+5.3%), ordinary income of 53.0B yen (+17.6%), and net income of 27.0B yen (+17.6%). Q3 cumulative progress rates stand at 70.2% for revenue, 58.0% for operating income, 66.2% for ordinary income, and 63.9% for net income against full-year targets. Operating income progress of 58.0% trails the standard 75% benchmark for Q3, indicating back-end loaded earnings assumptions requiring 18.9B yen in Q4 versus 8.7B yen quarterly average through Q3. Net income progress of 63.9% similarly implies 9.7B yen Q4 net income versus 5.8B yen quarterly average, suggesting significant Q4 recovery expectations. The company revised guidance this quarter, incorporating updated assumptions for second-half performance improvement. Achieving full-year targets requires Q4 operating income margin expansion to approximately 8.5% from the 5.6% nine-month average, implying substantial cost reduction, volume recovery, or favorable product mix shifts in the final quarter. The forecast assumes extraordinary loss impacts are contained to the first nine months, with cleaner Q4 earnings. Given the 0.2% revenue growth and 0.1% operating income growth through Q3, the full-year growth targets depend heavily on fourth-quarter execution, presenting upside opportunity if achieved but also downside risk if market conditions or operational improvements fail to materialize as planned.
Annual dividend of 9.00 yen per share is forecast, comprising the year-end payment. Based on forecast EPS of 47.03 yen, the payout ratio calculates to 19.1% against full-year projected earnings. However, based on Q3 cumulative net income of 17.3B yen and 57.4 million weighted average shares, interim EPS of 30.04 yen implies a 56.7% payout ratio if interim dividends of 8.00 yen per share plus forecast year-end 9.00 yen totaling 17.00 yen are considered. The calculation suggests sustainable dividend policy if full-year earnings targets are achieved, but elevated payout risk exists if Q4 profit falls short of projections. No share buyback programs were disclosed in the current period, indicating dividends represent the sole direct cash return mechanism. Treasury shares increased from 0.6B yen to 1.6B yen (156.5% increase in book value), suggesting some share repurchases occurred during the period, though details on volume and timing were not provided. Total shareholder return ratio equals the payout ratio absent explicit buyback disclosures. The dividend policy appears maintainable given cash reserves of 182.6B yen and adequate liquidity, though working capital intensity and capital expenditure requirements warrant monitoring for free cash flow adequacy to support ongoing distributions.
Working capital management risk remains elevated with inventory turnover of 203 days, receivables collection of 132 days, and cash conversion cycle of 276 days, substantially constraining cash generation and return on invested capital. Inefficient working capital deployment ties up 351.7B yen (27.4% of total assets), limiting financial flexibility and requiring improvement initiatives to normalize operating cash flows. Foreign exchange exposure represents material earnings volatility risk, with 9.9B yen FX gains contributing 37.8% of operating income in the current period. Currency fluctuations directly impact profitability given this dependency level, requiring hedging strategies or natural offsets to stabilize earnings. Absent disclosed hedging positions, FX risk remains a significant profit driver and potential detractor in future periods. Extraordinary loss recurrence risk stems from the 11.6B yen in current period charges, primarily 10.4B yen disaster losses. While classified as non-recurring, disaster exposure in operations or supply chains could generate future extraordinary charges, particularly given Japan's natural disaster risk profile and the company's asset-intensive manufacturing base with 538.6B yen in property, plant and equipment representing 42.0% of total assets.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 5.6% substantially underperforms the manufacturing industry median of 8.9% (IQR: 5.4%-12.7%), placing the company in the lower quartile. Net profit margin of 3.7% similarly trails the industry median of 6.5% (IQR: 3.3%-9.4%), indicating below-average conversion of revenue to bottom-line earnings. ROE of 2.5% significantly lags the industry median of 5.8% (IQR: 3.1%-8.4%), ranking in the bottom decile and reflecting severe capital efficiency underperformance. Return on invested capital warrants monitoring given ROIC of 2.0% versus industry median of 6.0% (IQR: 3.0%-10.0%).
Financial Health: Equity ratio of 54.4% aligns closely with industry median of 63.8% (IQR: 49.1%-74.8%), indicating comparable but slightly below-median capital structure conservatism. Current ratio of 234.2% substantially exceeds industry median of 287.0% (IQR: 213.0%-384.0%), demonstrating adequate but not exceptional short-term liquidity positioning within normal manufacturing ranges.
Efficiency: Asset turnover of 0.364x trails the industry median of 0.56x (IQR: 0.41-0.65), confirming below-average asset utilization and contributing to weak ROE through DuPont decomposition. Inventory turnover of 203 days significantly exceeds industry median of 112 days (IQR: 50-163 days), placing inventory management in the poorest quartile. Receivables turnover of 132 days also exceeds industry median of 85 days (IQR: 69-117 days), indicating collection inefficiency relative to peers. Operating working capital turnover warrants improvement given industry median of 112 days versus the company's 276-day cash conversion cycle.
Growth: Revenue growth of 0.2% YoY substantially lags industry median growth of 2.8% (IQR: -1.5% to +8.8%), indicating stagnant top-line expansion in a modestly growing sector. The company's performance places it in the bottom tercile for revenue momentum within the manufacturing peer group.
(Industry: Manufacturing sector, Comparison: FY2025 Q3 benchmarks, Source: Proprietary analysis)
Structural profitability challenges are evident with operating margin of 5.6% and ROE of 2.5% persistently underperforming manufacturing industry medians by 3.3 percentage points and 3.3 percentage points respectively, indicating systematic cost structure or pricing power disadvantages requiring strategic initiatives rather than cyclical recovery. Working capital intensity represents a critical value destruction mechanism, with 276-day cash conversion cycle substantially exceeding industry norms and consuming 351.7B yen in operating capital that generates minimal returns at 2.0% ROIC, suggesting immediate management focus on receivables acceleration and inventory optimization could unlock significant cash flow and return improvements. Non-operating income dependency creates earnings quality concerns, with 9.9B yen foreign exchange gains representing 37.8% of operating income and masking underlying operational stagnation, while 11.6B yen in extraordinary losses including disaster impacts highlight balance sheet vulnerabilities in an asset-intensive manufacturing model with 538.6B yen property, plant and equipment exposure.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.